Biological and prognostic role of acid cysteine proteinase inhibitor (ACPI, cystatin A) in non-small-cell lung cancer

Journal of Clinical Pathology

Volumn 60, Issue 5, 2007, Pages 515-519

  Leinonen, T ^b   Pirinen, R ^b   Bohm J ^b   Johansson, R ^b   Rinne, A ^c   Weber, E ^d   Kosma, V M ^a,b  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

^b KUOPIO UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TROMSØ   (Norway)

^d MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE INHIBITOR; STEFIN A;

ADENOCARCINOMA; ARTICLE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; OVERALL SURVIVAL; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR DIFFERENTIATION;

ADENOCARCINOMA; ADULT; AGED; CARCINOMA, LARGE CELL; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CYSTATINS; CYSTEINE PROTEINASE INHIBITORS; FOLLOW-UP STUDIES; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG NEOPLASMS; MIDDLE AGED; NEOPLASM STAGING; PRECANCEROUS CONDITIONS; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 34249871915     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2006.038711     Document Type: Article

References (31)

1. Abrahamson M, Alvarez-Fernandez M, Nathanson CM. Cystatins. Biochem Soc Symp 2003;70:179-99.
2. Kos J, Lah TT. Cysteine proteinases and their endogenous inhibitors: Target proteins for prognosis, diagnosis and therapy in cancer (review). Oncol Rep 1998;5:1349-61.
3. Järvinen M, Rinne A, Hopsu-Havu VK. Human cystatins in normal and diseased tissues - a review. Acta Histochem 1987;82:5-18.
4. Rinne A. Epidermal SH-protease inhibitor in human neoplasm and their metastases. Path Res Prod 1980;170:172-9.
5. Järvinen M, Hopsu-Havu VK. Alpha-N-benzoylarginine-2- naphthylamide hydrolase (cathepsin B1?) from rat skin. II. purification of the enzyme and demonstration of two inhibitors in the skin. Acta Chem Scand B 1975;29:772-80.
6. Rinne A, Järvinen M, Räsänen O. A protein reminiscent of the epidermal SH-protease inhibitor occurs in squamous epithelia of man and rat. Acta Histochem 1978;63:183-92.
7. Kominami E, Bando Y, Wakamatsu N, et al. Different tissue distributions of two types of thiol proteinase inhibitors from rat liver and epidermis. J Biochem (Tokyo) 1984;96:1437-42.
8. Rinne A, Alavaikko M, Järvinen M, et al. Demonstration of immunoreactive acid cysteine-proteinase inhibitor in reticulum cells of lymph node germinal centres. Virchows Arch B Cell Pathol Incl Mol Pathol 1983;43:121-6.
9. Kuopio T, Kankaanranta A, Jalava P, et al. Cysteine proteinase inhibitor cystatin A in breast cancer. Cancer Res 1998;58:432-6.
10. Söderström KO, Laato M, Wu P, et al. Expression of acid cysteine proteinase inhibitor (ACPI) in the normal human prostate, benign prostatic hyperplasia and adenocarcinoma. Int J Cancer 1995;62:1-4.
11. Vray B, Hartmann S, Hoebeke J. Immunomodulatory properties of cystatins. Cell Mol Life Sci 2002;59:1503-12.
12. Rinne A, Järvinen M, Räsänen O, et al. Demonstration of an epidermal SH-protease inhibitor in normal epithelium and in some human neoplasms - an immunological study (author's transl). Acta Histochem Suppl 1980;22:325-9.
13. Rinne A, Järvinen M, Räsänen O, et al. Acid and neutral cysteine proteinase inhibitor in normal uterine portio and in squamo-epithelial metaplasia, dysplasias and infiltrative carcinoma of the uterine portio. Exp Pathol 1984;26:67-70.
14. Pöllänen R, Pyykkönen K, Järvinen M, et al. Immunolocalization of cystatin A in condylomatous and dysplastic lesions of the human uterine cervix: Correlation with the presence and type of human papillomavirus infection. Int J Gynecol Pathol 1995;14:217-22.
15. Calkins CC, Sloane BF. Mammalian cysteine protease inhibitors: Biochemical properties and possible roles in tumor progression. Biol Chem Hoppe Seyler 1995;376:71-80.
16. Mirtti T, Alanen K, Kallajoki M, et al. Expression of cystatins, high molecular weight cytokeratin, and proliferation markers in prostatic adenocarcinoma and hyperplasia. Prostate 2003;54:290-8.
17. Strojan P, Budihna M, Smid L, et al. Prognostic significance of cysteine proteinases cathepsins B and L and their endogenous inhibitors stefins A and B in patients with squamous cell carcinoma of the head and neck. Clin Cancer Res 2000;6:1052-62.
18. Sinha AA, Quast BJ, Wilson MJ, et al. Prediction of pelvic lymph node metastasis by the ratio of cathepsin B to stefin A in patients with prostate carcinoma. Cancer 2002;94:3141-9.
19. Smid L, Strojan P, Budihna M, et al. Prognostic value of cathepsins B, D and steffins A and B in laryngeal carcinoma. Eur Arch Otorhinolaryngol 1997;254:150-3.
20. Eide TJ, Järvinen M, Hopsu-Havu VK, Maltau J, Rinne A. Immunolocalization of cystatin A in neoplastic, virus and inflammatory lesions of the uterine cervix. Acta Histochem 1992;93:241-8.
21. Heidtmann HH, Salge U, Abrahamson M, et al. Cathepsin B and cysteine proteinase inhibitors in human lung cancer cell lines. Clin Exp Metastasis 1997;15:368-81.
22. Pirinen R, Leinonen T, Böhm J, et al. Versican in non-small cell lung cancer: Relation to hyaluronan, clinicopathologic factors, and prognosis. Hum Pathol 2005;36:44-50.
23. Pirinen RT, Hirvikoski P, Johansson RT, et al. Reduced expression of alpha-catenin, beta-catenin, and gamma-catenin is associated with high cell proliferative activity and poor differentiation in non-small cell lung cancer. J Clin Pathol 2001;54:391-5.
24. Tumours of the lung. In:, Travis W, Brambilla E, Muller-Hermelink H, Harris C, eds. Tumours of the lung, pleura, thymus and heart. Lyon: IARCPress, 2004:9-122.
25. Alakurtti K, Weber E, Rinne R, et al. Loss of lysosomal association of cystatin B proteins representing progressive myoclonus epilepsy, EPM1, mutations. Eur J Hum Genet 2005;13:208-15.
26. Rinne A, Järvinen M, Dorn A, et al. Low-molecular cysteine protease inhibitors in the human palatine tonsil. Anat Anz 1986;161:215-30.
27. Zajc I, Sever N, Bervar A, et al. Expression of cysteine peptidase cathepsin L and its inhibitors stefins A and B in relation to tumorigenicity of breast cancer cell lines. Cancer Lett 2002;187:185-90.
28. Ebert E, Werle B, Julke B, et al. Expression of cysteine protease inhibitors stefin A, stefin B, and cystatin C in human lung tumor tissue. Adv Exp Med Biol 1997;421:259-65.
29. Krepela E, Prochazka J, Karova B, et al. Cysteine proteases and cysteine protease inhibitors in non-small cell lung cancer. Neoplasma 1998;45:318-31.
30. Sinha AA, Quast BJ, Wilson MJ, et al. Ratio of cathepsin B to stefin A identifies heterogeneity within gleason histologic scores for human prostate cancer. Prosfare 2001;48:274-84.
31. Lah TT, Kokalj-Kunovar M, Drobnic-Kosorok M, et al. Cystatins and cathepsins in breast carcinoma. Biol Chem Hoppe Seyler 1992;373:595-604.